Chimeric human immunodeficiency virus type 1/type 2 reverse transcriptases display reversed sensitivity to nonnucleoside analog inhibitors.

Documenti analoghi

• Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture.
  di: Richman, D, et al.
  Pubblicazione: (1991)
• Specific inhibition of the reverse transcriptase of human immunodeficiency virus type 1 and the chimeric enzymes of human immunodeficiency virus type 1 and type 2 by nonnucleoside inhibitors.
  di: Hizi, A, et al.
  Pubblicazione: (1993)
• Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication.
  di: Romero, D L, et al.
  Pubblicazione: (1991)
• Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1.
  di: Smerdon, S J, et al.
  Pubblicazione: (1994)
• Induction of Apoptosis by a Nonnucleoside Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitor
  di: Pilon, A. A., et al.
  Pubblicazione: (2002)